Interactions between extracellular signal‐regulated kinase 1/2 and P38 Map kinase pathways in the control of RUNX2 phosphorylation and transcriptional activity
dc.contributor.author | Ge, Chunxi | en_US |
dc.contributor.author | Yang, Qian | en_US |
dc.contributor.author | Zhao, Guisheng | en_US |
dc.contributor.author | Yu, Hong | en_US |
dc.contributor.author | Kirkwood, Keith L. | en_US |
dc.contributor.author | Franceschi, Renny T. | en_US |
dc.date.accessioned | 2012-03-16T15:57:55Z | |
dc.date.available | 2013-05-01T17:24:40Z | en_US |
dc.date.issued | 2012-03 | en_US |
dc.identifier.citation | Ge, Chunxi; Yang, Qian; Zhao, Guisheng; Yu, Hong; Kirkwood, Keith L; Franceschi, Renny T (2012). "Interactions between extracellular signal‐regulated kinase 1/2 and P38 Map kinase pathways in the control of RUNX2 phosphorylation and transcriptional activity." Journal of Bone and Mineral Research 27(3): 538-551. <http://hdl.handle.net/2027.42/90254> | en_US |
dc.identifier.issn | 0884-0431 | en_US |
dc.identifier.issn | 1523-4681 | en_US |
dc.identifier.uri | https://hdl.handle.net/2027.42/90254 | |
dc.description.abstract | RUNX2, a key transcription factor for osteoblast differentiation, is regulated by ERK1/2 and p38 MAP kinase‐mediated phosphorylation. However, the specific contribution of each kinase to RUNX2‐dependent transcription is not known. Here we investigate ERK and p38 regulation of RUNX2 using a unique P‐RUNX2‐specific antibody. Both MAP kinases stimulated RUNX2 Ser319 phosphorylation and transcriptional activity. However, a clear preference for ERK1 versus p38α/β was found when the ability of these MAPKs to phosphorylate and activate RUNX2 was compared. Similarly, ERK1 preferentially bound to a consensus MAPK binding site on RUNX2 that was essential for the activity of either kinase. To assess the relative contribution of ERK1/2 and p38 to osteoblast gene expression, MC3T3‐E1 preosteoblast cells were grown in control or ascorbic acid (AA)‐containing medium ± BMP2/7. AA‐induced gene expression, which requires collagen matrix synthesis, was associated with parallel increases in P‐ERK and RUNX2‐S319‐P in the absence of any changes in P‐p38. This response was blocked by ERK, but not p38, inhibition. Significantly, in the presence of AA, BMP2/7 synergistically stimulated RUNX2 S319 phosphorylation and transcriptional activity without affecting total RUNX2 and this response was totally dependent on ERK/MAPK activity. In contrast, although p38 inhibition partially blocked BMP‐dependent transcription, it did not affect RUNX2 S319 phosphorylation, suggesting the involvement of other phosphorylation sites and/or transcription factors in this response. Based on this work, we conclude that extracellular matrix and BMP regulation of RUNX2 phosphorylation and transcriptional activity in osteoblasts is predominantly mediated by ERK rather than p38 MAPKs. © 2012 American Society for Bone and Mineral Research. | en_US |
dc.publisher | Wiley Subscription Services, Inc., A Wiley Company | en_US |
dc.subject.other | MAPK | en_US |
dc.subject.other | RUNX2 | en_US |
dc.subject.other | PHOSPHORYLATION | en_US |
dc.subject.other | TRANSCRIPTION | en_US |
dc.subject.other | OSTEOBLAST | en_US |
dc.title | Interactions between extracellular signal‐regulated kinase 1/2 and P38 Map kinase pathways in the control of RUNX2 phosphorylation and transcriptional activity | en_US |
dc.type | Article | en_US |
dc.rights.robots | IndexNoFollow | en_US |
dc.subject.hlbsecondlevel | Internal Medicine and Specialities | en_US |
dc.subject.hlbtoplevel | Health Sciences | en_US |
dc.description.peerreviewed | Peer Reviewed | en_US |
dc.contributor.affiliationum | Department of Periodontics and Oral Medicine, University of Michigan School of Dentistry, 1011 N. University Ave., Ann Arbor, MI 48109‐1078, USA. | en_US |
dc.contributor.affiliationum | Department of Biological Chemistry, School of Medicine, University of Michigan, Ann Arbor, MI, USA | en_US |
dc.contributor.affiliationum | Department of Periodontics and Oral Medicine, School of Dentistry, University of Michigan, Ann Arbor, MI, USA | en_US |
dc.contributor.affiliationother | Department of Craniofacial Biology and the Center for Oral Health Research, College of Dental Medicine, Medical University of South Carolina, Charleston, SC, USA | en_US |
dc.identifier.pmid | 22072425 | en_US |
dc.description.bitstreamurl | http://deepblue.lib.umich.edu/bitstream/2027.42/90254/1/561_ftp.pdf | |
dc.identifier.doi | 10.1002/jbmr.561 | en_US |
dc.identifier.source | Journal of Bone and Mineral Research | en_US |
dc.identifier.citedreference | Yang SH, Whitmarsh AJ, Davis RJ, Sharrocks AD. Differential targeting of MAP kinases to the ETS‐domain transcription factor Elk‐1. EMBO J. 1998; 17 ( 6 ): 1740 – 9. | en_US |
dc.identifier.citedreference | Li Y, Ge C, Franceschi RT. Differentiation‐dependent association of phosphorylated extracellular signal‐regulated kinase with the chromatin of osteoblast‐related genes. J Bone Miner Res. 2010; 25 ( 1 ): 154 – 63. | en_US |
dc.identifier.citedreference | Ge C, Xiao G, Jiang D, Franceschi RT. Critical role of the extracellular signal‐regulated kinase‐MAPK pathway in osteoblast differentiation and skeletal development. J Cell Biol. 2007; 176 ( 5 ): 709 – 18. | en_US |
dc.identifier.citedreference | Matsushita T, Chan YY, Kawanami A, Balmes G, Landreth GE, Murakami S. Extracellular signal‐regulated kinase 1 (ERK1) and ERK2 play essential roles in osteoblast differentiation and in supporting osteoclastogenesis. Mol Cell Biol. 2009; 29 ( 21 ): 5843 – 57. | en_US |
dc.identifier.citedreference | Greenblatt MB, Shim JH, Zou W, Sitara D, Schweitzer M, Hu D, Lotinun S, Sano Y, Baron R, Park JM, Arthur S, Xie M, Schneider MD, Zhai B, Gygi S, Davis R, Glimcher LH. The p38 MAPK pathway is essential for skeletogenesis and bone homeostasis in mice. J Clin Invest. 2010; 120 ( 7 ): 2457 – 73. | en_US |
dc.identifier.citedreference | Shim JH, Greenblatt MB, Xie M, Schneider MD, Zou W, Zhai B, Gygi S, Glimcher LH. TAK1 is an essential regulator of BMP signalling in cartilage. EMBO J. 2009; 28 ( 14 ): 2028 – 41. | en_US |
dc.identifier.citedreference | Ducy P, Karsenty G. Two distinct osteoblast‐specific cis‐acting elements control expression of a mouse osteocalcin gene. Mol Cell Biol. 1995; 15 ( 4 ): 1858 – 69. | en_US |
dc.identifier.citedreference | Thirunavukkarasu K, Mahajan M, McLarren KW, Stifani S, Karsenty G. Two domains unique to osteoblast‐specific transcription factor Osf2/Cbfa1 contribute to its transactivation function and its inability to heterodimerize with Cbfbeta. Mol Cell Biol. 1998; 18 ( 7 ): 4197 – 208. | en_US |
dc.identifier.citedreference | Stewart S, Sundaram M, Zhang Y, Lee J, Han M, Guan KL. Kinase suppressor of Ras forms a multiprotein signaling complex and modulates MEK localization. Mol Cell Biol. 1999; 19 ( 8 ): 5523 – 34. | en_US |
dc.identifier.citedreference | Zheng CF, Guan KL. Properties of MEKs, the kinases that phosphorylate and activate the extracellular signal‐regulated kinases. J Biol Chem. 1993; 268 ( 32 ): 23933 – 9. | en_US |
dc.identifier.citedreference | Huang S, Jiang Y, Li Z, Nishida E, Mathias P, Lin S, Ulevitch RJ, Nemerow GR, Han J. Apoptosis signaling pathway in T cells is composed of ICE/Ced‐3 family proteases and MAP kinase kinase 6b. Immunity. 1997; 6 ( 6 ): 739 – 49. | en_US |
dc.identifier.citedreference | Hardy S, Kitamura M, Harris‐Stansil T, Dai Y, Phipps ML. Construction of adenovirus vectors through Cre‐lox recombination. J Virol. 1997; 71 ( 3 ): 1842 – 9. | en_US |
dc.identifier.citedreference | Xiao G, Cui Y, Ducy P, Karsenty G, Franceschi RT. Ascorbic acid‐dependent activation of the osteocalcin promoter in MC3T3‐E1 preosteoblasts: requirement for collagen matrix synthesis and the presence of an intact OSE2 sequence. Mol Endocrinol. 1997; 11 ( 8 ): 1103 – 13. | en_US |
dc.identifier.citedreference | Sharrocks AD, Yang SH, Galanis A. Docking domains and substrate‐specificity determination for MAP kinases. Trends Biochem Sci. 2000; 25 ( 9 ): 448 – 53. | en_US |
dc.identifier.citedreference | Zhang Y, Su J, Yu J, Bu X, Ren T, Liu X, Yao L. An essential role of discoidin domain receptor 2 (DDR2) in osteoblast differentiation and chondrocyte maturation via modulation of Runx2 activation. J Bone Miner Res. 2010; 26 ( 3 ): 604 – 17. | en_US |
dc.identifier.citedreference | Suzawa M, Tamura Y, Fukumoto S, Miyazono K, Fujita T, Kato S, Takeuchi Y. Stimulation of Smad1 transcriptional activity by Ras‐extracellular signal‐regulated kinase pathway: a possible mechanism for collagen‐dependent osteoblastic differentiation. J Bone Miner Res. 2002; 17 ( 2 ): 240 – 8. | en_US |
dc.identifier.citedreference | Franceschi RT, Iyer BS. Relationship between collagen synthesis and expression of the osteoblast phenotype in MC3T3‐E1 cells. J Bone Miner Res. 1992; 7 ( 2 ): 235 – 46. | en_US |
dc.identifier.citedreference | Kefaloyianni E, Gaitanaki C, Beis I. ERK1/2 and p38‐MAPK signalling pathways, through MSK1, are involved in NF‐kappaB transactivation during oxidative stress in skeletal myoblasts. Cell Signal. 2006; 18 ( 12 ): 2238 – 51. | en_US |
dc.identifier.citedreference | Deak M, Clifton AD, Lucocq LM, Alessi DR. Mitogen‐ and stress‐activated protein kinase‐1 (MSK1) is directly activated by MAPK and SAPK2/p38, and may mediate activation of CREB. EMBO J. 1998; 17 ( 15 ): 4426 – 41. | en_US |
dc.identifier.citedreference | Nishimura M, Shin MS, Singhirunnusorn P, Suzuki S, Kawanishi M, Koizumi K, Saiki I, Sakurai H. TAK1‐mediated serine/threonine phosphorylation of epidermal growth factor receptor via p38/extracellular signal‐regulated kinase: NF‐{kappa}B‐independent survival pathways in tumor necrosis factor alpha signaling. Mol Cell Biol. 2009; 29 ( 20 ): 5529 – 39. | en_US |
dc.identifier.citedreference | Akella R, Moon TM, Goldsmith EJ. Unique MAP Kinase binding sites. Biochim Biophys Acta. 2008; 1784 ( 1 ): 48 – 55. | en_US |
dc.identifier.citedreference | Hotokezaka H, Sakai E, Kanaoka K, Saito K, Matsuo K, Kitaura H, Yoshida N, Nakayama K. U0126 and PD98059, specific inhibitors of MEK, accelerate differentiation of RAW264.7 cells into osteoclast‐like cells. J Biol Chem. 2002; 277 ( 49 ): 47366 – 72. | en_US |
dc.identifier.citedreference | Prasadam I, van Gennip S, Friis T, Shi W, Crawford R, Xiao Y. ERK‐1/2 and p38 in the regulation of hypertrophic changes of normal articular cartilage chondrocytes induced by osteoarthritic subchondral osteoblasts. Arthritis Rheum. 2010; 62 ( 5 ): 1349 – 60. | en_US |
dc.identifier.citedreference | Xing W, Singgih A, Kapoor A, Alarcon CM, Baylink DJ, Mohan S. Nuclear factor‐E2‐related factor‐1 mediates ascorbic acid induction of osterix expression via interaction with antioxidant‐responsive element in bone cells. J Biol Chem. 2007; 282 ( 30 ): 22052 – 61. | en_US |
dc.identifier.citedreference | Asahina I, Sampath TK, Nishimura I, Hauschka PV. Human osteogenic protein‐1 induces both chondroblastic and osteoblastic differentiation of osteoprogenitor cells derived from newborn rat calvaria. J Cell Biol. 1993; 123 ( 4 ): 921 – 33. | en_US |
dc.identifier.citedreference | Hassan MQ, Tare RS, Lee SH, Mandeville M, Morasso MI, Javed A, van Wijnen AJ, Stein JL, Stein GS, Lian JB. BMP2 commitment to the osteogenic lineage involves activation of Runx2 by DLX3 and a homeodomain transcriptional network. J Biol Chem. 2006; 281 ( 52 ): 40515 – 26. | en_US |
dc.identifier.citedreference | Ulsamer A, Ortuno MJ, Ruiz S, Susperregui AR, Osses N, Rosa JL, Ventura F. BMP‐2 induces Osterix expression through up‐regulation of Dlx5 and its phosphorylation by p38. J Biol Chem. 2008; 283 ( 7 ): 3816 – 26. | en_US |
dc.identifier.citedreference | Ortuno MJ, Ruiz‐Gaspa S, Rodriguez‐Carballo E, Susperregui AR, Bartrons R, Rosa JL, Ventura F. p38 regulates expression of osteoblast‐specific genes by phosphorylation of osterix. J Biol Chem. 2010; 285 ( 42 ): 31985 – 94. | en_US |
dc.identifier.citedreference | Koga T, Matsui Y, Asagiri M, Kodama T, de Crombrugghe B, Nakashima K, Takayanagi H. NFAT and Osterix cooperatively regulate bone formation. Nat Med. 2005; 11 ( 8 ): 880 – 5. | en_US |
dc.identifier.citedreference | Ducy P, Starbuck M, Priemel M, Shen J, Pinero G, Geoffroy V, Amling M, Karsenty G. A Cbfa1‐dependent genetic pathway controls bone formation beyond embryonic development. Genes Dev. 1999; 13 ( 8 ): 1025 – 36. | en_US |
dc.identifier.citedreference | Komori T, Yagi H, Nomura S, Yamaguchi A, Sasaki K, Deguchi K, Shimizu Y, Bronson RT, Gao YH, Inada M, Sato M, Okamoto R, Kitamura Y, Yoshiki S, Kishimoto T. Targeted disruption of Cbfa1 results in a complete lack of bone formation owing to maturational arrest of osteoblasts. Cell. 1997; 89 ( 5 ): 755 – 64. | en_US |
dc.identifier.citedreference | Otto F, Thornell AP, Crompton T, Denzel A, Gilmour KC, Rosewell IR, Stamp GW, Beddington RS, Mundlos S, Olsen BR, Selby PB, Owen MJ. Cbfa1, a candidate gene for cleidocranial dysplasia syndrome, is essential for osteoblast differentiation and bone development. Cell. 1997; 89 ( 5 ): 765 – 71. | en_US |
dc.identifier.citedreference | Nakashima K, Zhou X, Kunkel G, Zhang Z, Deng JM, Behringer RR, de Crombrugghe B. The novel zinc finger‐containing transcription factor osterix is required for osteoblast differentiation and bone formation. Cell. 2002; 108 ( 1 ): 17 – 29. | en_US |
dc.identifier.citedreference | Bialek P, Kern B, Yang X, Schrock M, Sosic D, Hong N, Wu H, Yu K, Ornitz DM, Olson EN, Justice MJ, Karsenty G. A twist code determines the onset of osteoblast differentiation. Dev Cell. 2004; 6 ( 3 ): 423 – 35. | en_US |
dc.identifier.citedreference | Tou L, Quibria N, Alexander JM. Transcriptional regulation of the human Runx2/Cbfa1 gene promoter by bone morphogenetic protein‐7. Mol Cell Endocrinol. 2003; 205 ( 1–2 ): 121 – 9. | en_US |
dc.identifier.citedreference | Xiao G, Jiang D, Thomas P, Benson MD, Guan K, Karsenty G, Franceschi RT. MAPK pathways activate and phosphorylate the osteoblast‐specific transcription factor, Cbfa1. J Biol Chem. 2000; 275 ( 6 ): 4453 – 9. | en_US |
dc.identifier.citedreference | Franceschi RT, Ge C, Xiao G, Roca H, Jiang D. Transcriptional regulation of osteoblasts. Ann NY Acad Sci. 2007; 1116: 196 – 207. | en_US |
dc.identifier.citedreference | Xiao G, Jiang D, Gopalakrishnan R, Franceschi RT. Fibroblast growth factor 2 induction of the osteocalcin gene requires MAPK activity and phosphorylation of the osteoblast transcription factor, Cbfa1/Runx2. J Biol Chem. 2002; 277 ( 39 ): 36181 – 7. | en_US |
dc.identifier.citedreference | Hurley MM, Marcello K, Abreu C, Kessler M. Signal transduction by basic fibroblast growth factor in rat osteoblastic Py1a cells. J Bone Miner Res. 1996; 11 ( 9 ): 1256 – 63. | en_US |
dc.identifier.citedreference | Takeuchi Y, Suzawa M, Kikuchi T, Nishida E, Fujita T, Matsumoto T. Differentiation and transforming growth factor‐beta receptor down‐regulation by collagen‐alpha2beta1 integrin interaction is mediated by focal adhesion kinase and its downstream signals in murine osteoblastic cells. J Biol Chem. 1997; 272 ( 46 ): 29309 – 16. | en_US |
dc.identifier.citedreference | Xiao G, Wang D, Benson MD, Karsenty G, Franceschi RT. Role of the alpha2‐integrin in osteoblast‐specific gene expression and activation of the Osf2 transcription factor. J Biol Chem. 1998; 273 ( 49 ): 32988 – 94. | en_US |
dc.identifier.citedreference | Xiao G, Gopalakrishnan R, Jiang D, Reith E, Benson MD, Franceschi RT. Bone morphogenetic proteins, extracellular matrix, and mitogen‐activated protein kinase signaling pathways are required for osteoblast‐specific gene expression and differentiation in MC3T3‐E1 cells. J Bone Miner Res. 2002; 17 ( 1 ): 101 – 10. | en_US |
dc.identifier.citedreference | Khatiwala CB, Kim PD, Peyton SR, Putnam AJ. ECM compliance regulates osteogenesis by influencing MAPK signaling downstream of RhoA and ROCK. J Bone Miner Res. 2009; 24 ( 5 ): 886 – 98. | en_US |
dc.identifier.citedreference | You J, Reilly GC, Zhen X, Yellowley CE, Chen Q, Donahue HJ, Jacobs CR. Osteopontin gene regulation by oscillatory fluid flow via intracellular calcium mobilization and activation of mitogen‐activated protein kinase in MC3T3‐E1 osteoblasts. J Biol Chem. 2001; 276 ( 16 ): 13365 – 71. | en_US |
dc.identifier.citedreference | Boutahar N, Guignandon A, Vico L, Lafage‐Proust MH. Mechanical strain on osteoblasts activates autophosphorylation of focal adhesion kinase and proline‐rich tyrosine kinase 2 tyrosine sites involved in ERK activation. J Biol Chem. 2004; 279 ( 29 ): 30588 – 99. | en_US |
dc.identifier.citedreference | Ge C, Xiao G, Jiang D, Yang Q, Hatch NE, Roca H, Franceschi RT. Identification and functional characterization of ERK/MAPK phosphorylation sites in the Runx2 transcription factor. J Biol Chem. 2009; 284 ( 47 ): 32533 – 43. | en_US |
dc.owningcollname | Interdisciplinary and Peer-Reviewed |
Files in this item
Remediation of Harmful Language
The University of Michigan Library aims to describe library materials in a way that respects the people and communities who create, use, and are represented in our collections. Report harmful or offensive language in catalog records, finding aids, or elsewhere in our collections anonymously through our metadata feedback form. More information at Remediation of Harmful Language.
Accessibility
If you are unable to use this file in its current format, please select the Contact Us link and we can modify it to make it more accessible to you.